Benjamin L. Palleiko - Feb 11, 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
CFO, CBO
Signature
/s/ Benjamin L. Palleiko
Stock symbol
KALV
Transactions as of
Feb 11, 2024
Transactions value $
$0
Form type
4
Date filed
2/13/2024, 09:23 AM
Previous filing
Nov 21, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Award +87.5K +77.82% 200K Feb 11, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Performance Stock Units Award $0 +83.3K $0.00 83.3K Feb 11, 2024 Common Stock 83.3K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned upon the vesting of a percentage of the performance stock units ("PSUs") granted to the Reporting Person on March 11, 2022. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of performance data metric goals ("Performance Metrics"). 100% of the total number of shares subject to the PSUs vested on February 11, 2024, upon Performance Metrics achieved.
F2 Each PSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F3 Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on January 10, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of Performance Metrics. 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of February 17, 2024, upon Performance Metrics achieved, subject to continued service through each vesting date.